Appointment booking for Dr. John Weisenreider, MD is currently not available.Dr. John Weisenreider, MD has not yet fully activated their profile on DiabetesIQ.
Dr. John Weisenreider, MD (he/him) is a Internist in Hawley, PA with over 18 years of experience. What is your opinion of Dr. John Weisenreider, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. John Weisenreider, MD has received over $3,115 which includes payments from the following companies:
$668.39 from AstraZeneca Pharmaceuticals LP
$517.72 from GlaxoSmithKline, LLC.
$318.19 from Merck Sharp & Dohme Corporation
$214.22 from Amgen Inc.
$211.03 from sanofi-aventis U.S. LLC
$202.56 from Janssen Pharmaceuticals, Inc
$199.94 from Novo Nordisk Inc
$114.32 from Boehringer Ingelheim Pharmaceuticals, Inc.
$104.58 from Pfizer Inc.
$86.18 from Grifols USA, LLC
$81.79 from LILLY USA, LLC
$64.83 from Purdue Pharma L.P.
$60.78 from Takeda Pharmaceuticals America, Inc.
$55.46 from Eisai Inc.
$36.70 from Mylan Specialty L.P.
$34.15 from Allergan Inc.
$33.96 from Abbott Laboratories
$33.12 from AbbVie, Inc.
$18.81 from Endo Pharmaceuticals Inc.
$18.33 from Novartis Pharmaceuticals Corporation
Payments received by Dr. John Weisenreider, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!